GlassScriptPhysician profile
Alethia Sellers
NPI 1154543197
$3,776.07
in general payments reported to CMS, 2019-2025
14 companies · $739 in 2025
The $739 reported for 2025 was more than what 93% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $207 · 2023: $1,895 · 2024: $935 · 2025: $739.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,199 · Travel and Lodging: $871 · Grant: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,198.55 |
| Travel and Lodging | $870.50 |
| Grant | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spr Therapeutics, INC | $982.47 | 2022-2025 | Sprint Pns System |
| Pacira Pharmaceuticals Incorporated | $642.37 | 2023-2025 | Iovera, Exparel, Zilretta |
| Abbott Laboratories | $593.33 | 2022-2025 | Proclaim, Ionicrf |
| Boston Scientific Corporation | $590.00 | 2023-2024 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $281.24 | 2022-2024 | Intellis Adaptivestim |
| Nalu Medical, INC. | $159.60 | 2023-2025 | Nalu Neurostimulation System |
| Nevro Corp. | $115.13 | 2022-2024 | Senza |
| Mml US, INC. | $110.33 | 2023-2025 | Reactiv8 |
| Averitas Pharma INC. | $90.08 | 2023-2024 | Qutenza |
| Novo Nordisk INC | $75.43 | 2024-2025 | Wegovy |
| Lilly USA, LLC | $60.10 | 2023-2024 | Emgality, Jardiance, Zepbound |
| Avanos Medical | $42.31 | 2024 | Coolief* Cooled Radiofrequency |
| Stratus Medical, LLC | $19.12 | 2023 | Nimbus |
| Curonix LLC | $14.56 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alethia Sellers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.